Swing Selects Curavit to Provide Virtual Trial Site Services for Fibromyalgia

Curavit Clinical Research has been selected by Swing Therapeutics to be a virtual site for its trial on investigating digital therapeutics (DTx) for fibromyalgia. Curavit will remotely be conducting the study, recruiting participants virtually from across the United States, to participate in a 12-week RCT. Curavit with Swing will prioritize patient recruitment through virtual services where patients may feel less burdened and be more likely to stay with the duration of the trial.

Read more about this news release here.